Neuropace (NPCE)

• Market cap: $524M
• 1 day: -1.66%
• 5 days: -3.33%
• 1 month: -9.16%
• 3 months: 14.87%
• 6 months: -7.19%
• Year to date: 1.32%
• 1 year: 45.41%
• 5 years: -38.02%
• 10 years: -38.42%
• Sector: Healthcare
• Industry: Medical Devices

About: NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Employees: 220